Norges Bank’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,155
| Closed | -$760K | – | 1752 |
|
|
2025
Q1 | $760K | Sell |
84,155
-104,463
| -55% | -$1.1M | ﹤0.01% | 1657 |
|
|
2024
Q4 | $2.47M | Sell |
188,618
-87,766
| -32% | -$1.17M | ﹤0.01% | 1666 |
|
|
2024
Q3 | $4.34M | Sell |
276,384
-67,116
| -20% | -$1.02M | ﹤0.01% | 1555 |
|
|
2024
Q2 | $4.64M | Sell |
343,500
-213,859
| -38% | -$4.38M | ﹤0.01% | 1581 |
|
|
2024
Q1 | $15.4M | Buy |
557,359
+82,000
| +17% | +$1.82M | ﹤0.01% | 1334 |
|
|
2023
Q4 | $9.16M | Sell |
475,359
-187,500
| -28% | -$3.4M | ﹤0.01% | 1515 |
|
|
2023
Q3 | $10.7M | Buy |
662,859
+96,400
| +17% | +$1.71M | ﹤0.01% | 1446 |
|
|
2023
Q2 | $10.8M | Buy |
566,459
+91,100
| +19% | +$1.62M | ﹤0.01% | 1506 |
|
|
2023
Q1 | $6.92M | Buy |
475,359
+160,592
| +51% | +$2.88M | ﹤0.01% | 1679 |
|
|
2022
Q4 | $6.15M | Hold |
314,767
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q3 | $7.59M | Sell |
314,767
-69,081
| -18% | -$2.13M | ﹤0.01% | 1624 |
|
|
2022
Q2 | $12.1M | Buy |
383,848
+59,331
| +18% | +$2.15M | ﹤0.01% | 1472 |
|
|
2022
Q1 | $14.3M | Buy |
324,517
+18,355
| +6% | +$788K | ﹤0.01% | 1558 |
|
|
2021
Q4 | $13.3M | Buy |
306,162
+30,729
| +11% | +$1.2M | ﹤0.01% | 1654 |
|
|
2021
Q3 | $8.62M | Buy |
+275,433
| New | +$10.8M | ﹤0.01% | 1811 |
|
|
2019
Q2 | – | Sell |
-356,308
| Closed | -$1.46M | – | 2128 |
|
|
2019
Q1 | $1.46M | Sell |
356,308
-624,418
| -64% | -$3.95M | ﹤0.01% | 2028 |
|
|
2018
Q4 | $6.21M | Hold |
980,726
| – | – | ﹤0.01% | 1883 |
|
|
2018
Q3 | $16.2M | Buy |
980,726
+183,120
| +23% | +$3.11M | 0.01% | 1628 |
|
|
2018
Q2 | $13.3M | Buy |
797,606
+126,088
| +19% | +$2.04M | ﹤0.01% | 1723 |
|
|
2018
Q1 | $10.4M | Buy |
671,518
+110,051
| +20% | +$1.96M | ﹤0.01% | 1734 |
|
|
2017
Q4 | $10.6M | Sell |
561,467
-108,458
| -16% | -$2.4M | ﹤0.01% | 1718 |
|
|
2017
Q3 | $19.6M | Sell |
669,925
-85,940
| -11% | -$2.54M | 0.01% | 1457 |
|
|
2017
Q2 | $24.3M | Sell |
755,865
-230,708
| -23% | -$7.57M | 0.01% | 1261 |
|
|
2017
Q1 | $34.1M | Buy |
986,573
+193,651
| +24% | +$6.92M | 0.01% | 981 |
|
|
2016
Q4 | $28M | Sell |
792,922
-269,757
| -25% | -$9.12M | 0.01% | 1076 |
|
|
2016
Q3 | $35.3M | Buy |
1,062,679
+46,716
| +5% | +$1.64M | 0.02% | 829 |
|
|
2016
Q2 | $38M | Buy |
1,015,963
+63,456
| +7% | +$2.38M | 0.02% | 779 |
|
|
2016
Q1 | $38.5M | Hold |
952,507
| – | – | 0.02% | 751 |
|
|
2015
Q4 | $34.3M | Buy |
952,507
+67,027
| +8% | +$2.42M | 0.02% | 804 |
|
|
2015
Q3 | $28.3M | Buy |
885,480
+153,685
| +21% | +$5.23M | 0.01% | 909 |
|
|
2015
Q2 | $24.9M | Buy |
731,795
+60,580
| +9% | +$2.04M | 0.01% | 1063 |
|
|
2015
Q1 | $22.7M | Buy |
671,215
+29,000
| +5% | +$1.01M | 0.01% | 1127 |
|
|
2014
Q4 | $22.5M | Sell |
642,215
-20,880
| -3% | -$703K | 0.01% | 1134 |
|
|
2014
Q3 | $21.7M | Sell |
663,095
-663,095
| -50% | -$22.6M | 0.01% | 1083 |
|
|
2014
Q2 | $45.1M | Buy |
1,326,190
+812,055
| +158% | +$27.8M | 0.01% | 1089 |
|
|
2014
Q1 | $18M | Hold |
514,135
| – | – | 0.01% | 1206 |
|
|
2013
Q4 | $18.8M | Hold |
514,135
| – | – | 0.01% | 1152 |
|
|
2013
Q3 | $17.8M | Buy |
514,135
+202,537
| +65% | +$7.09M | 0.01% | 1167 |
|
|
2013
Q2 | $10.5M | Buy |
+311,598
| New | +$10.3M | 0.01% | 1438 |
|
Other funds holding ACH
CCM
PCMI
Norges Bank's ACH Position: Q2 2025 in Review
Norges Bank sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 84,155 shares — an estimated $760K sold.
Norges Bank first reported a position in ACH in Q2 2013 and held it in 39 quarters. The position peaked at $45.1M in Q2 2014. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.
- Norges Bank reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
- Norges Bank sold 84,155 Accendra Health shares in Q2 2025, an estimated $760K.
- Norges Bank first reported a position in Accendra Health in Q2 2013 and held it in 39 quarters.
- Norges Bank's Accendra Health position peaked at $45.1M in Q2 2014.
- 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.
Based on Norges Bank's 13F filing for Q2 2025, filed 13 Aug 2025.